We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Featured Industry Insights

Latest Industry Insights

Five male and female cell and gene therapy scientists with their arms crossed.
Industry Insight

From Bench to Boardroom: Leading Cell and Gene Therapy Through Uncertainty

In this opinion piece, Dr. Stella Vnook explores how cell and gene therapy leaders are adapting to today’s financial and regulatory headwinds, offering actionable insights into how biotech CEOs are rethinking capital strategy.
Three scientists in lab coats discussing their research in a lab with lab glassware on the shelf behind them.
Industry Insight

Driving Innovation While Navigating Global Pressures: How One Life Science Company Is Evolving With the Market

As global scientific and regulatory landscapes shift, companies across the life sciences sector are under growing pressure to adapt. Hear how Phenomenex are taking a proactive approach.
A scientist holding up a vial containing a DNA double helix, representing cell and gene therapy manufacturing.
Industry Insight

FDA Delays Cell and Gene Therapy Approvals Following CMC Issues

Explore why cell and gene therapy manufacturing failures are now a leading cause of FDA rejections and how to avoid them.
A close up of a woman's eye, the target of a new stem cell therapy to treat blindness.
Industry Insight

A Stem Cell Therapy Resembling a Contact Lens Hopes To Cure Blindness

Stem cell therapy using iPSC technology on the surface of the eye could cure blindness by replacing damaged corneal cells – a new hope for vision restoration.
3D illustration of an RNA strand representing genetic material used in gene delivery.
Industry Insight

Overcoming the Gene Therapy Delivery Challenge

Nucleic acid therapies offer targeted treatment for genetic diseases, but delivery remains a key hurdle. Explore how advances in lipid nanoparticles and protein barcoding are enabling more precise, scalable, tissue-specific delivery.
Microscopic view of cells with visible nuclei in a blue-stained environment.
Industry Insight

Rethinking Adherent Cell Culture for Scalable, Sustainable Biomanufacturing

Joel Eichmann discusses the challenges of scaling adherent cell culture and the innovations helping to streamline the transition from discovery to GMP manufacturing.
Molecular structure emerging from capsules, symbolizing drug discovery in functional proteomics.
Industry Insight

Advancing Drug Discovery With Functional Proteomics

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate instrumentation, software and consumables to support early-stage pharma innovation.
Delivery of stem cells using a syringe.
Industry Insight

Overcoming In Vivo Delivery Challenges With Image-Guided Innovation

Dr. Tomek Czernuszewicz shares insights on the limitations of traditional delivery techniques and how Revvity is advancing in vivo imaging through AI-powered tools.
An adult holding a baby's hand, signifying the first patient to receive a customized gene therapy was a child.
Industry Insight

How the First Customized Gene Therapy Was Created in Six Months

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, CPS1, about how the product was created in just six months.
Digital illustration of a glowing circular DNA strand representing minicircle DNA structure.
Industry Insight

Unlocking the Potential of Minicircle DNA

In this interview, we explore the limitations of pDNA, the advantages of mcDNA and how NunaBio’s technology could unlock new possibilities for safer, more efficient gene therapy.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter